Marked Reduction of Alcohol Dehydrogenase in Keratoconus Corneal Fibroblasts

Overview

Journal Mol Vis

Specialties Cell Biology
Molecular Biology
Ophthalmology

Date 2009 Apr 15

PMID 19365573

Citations 10

Authors

V V Mootha

J M Kanoff

J Shankardas

S Dimitrijevich

Affiliations

Soon will be listed here.

Abstract

Purpose: To identify differentially expressed genes in keratoconus (KC) corneal fibroblasts.

Methods: Stromal keratocytes (having a fibroblast morphology) from KC keratoplasty specimens and eye bank donor corneas were isolated and expanded using a serum containing medium. RNA was isolated from three KC fibroblast cultures and five eye bank donor cornea fibroblast cultures. The targets from the cultured fibroblasts were hybridized to the Affymetrix U133 Plus 2.0 microarrays. Western blot analyses of cell lysates were performed to examine protein levels of interest in the two groups. Protein levels of select differentially expressed genes were further examined by immunohistochemistry. Keratocyte staining of archived KC keratoplasty specimens were graded using a 0 to 3+ scale and compared to five archived whole globes having normal corneas as well as to 10 Fuchs' dystrophy keratoplasty specimens.

Results: Microarray analysis revealed up to a 212 fold reduction in the mRNA levels of alcohol dehydrogenase (class 1) beta polypeptide (ADH1B) in KC fibroblasts (p=0.04). Decreased alcohol dehydrogenase in KC fibroblasts was confirmed by western blot analysis of early passage primary keratocyte cell lysates. Immunohistochemistry using a monoclonal mouse immunoglobulin G (IgG) against human liver alcohol dehydrogenase revealed a dramatic difference in protein staining in the keratocytes of the KC group compared to the normal cornea group. Immunohistochemistry also showed decreased immunostaining against alcohol dehydrogenase in the KC stromal sections compared to those obtained from Fuchs' endothelial corneal dystrophy samples.

Conclusions: Decreased alcohol dehydrogenase in KC corneal fibroblasts represents a strong marker and possible mediator of keratoconus.

Citing Articles

Integrating network pharmacology and computational biology to propose Yiqi Sanjie formula's mechanisms in treating NSCLC: molecular docking, ADMET, and molecular dynamics simulation.

Wang Y, He G, Zloh M, Shen T, He Z Transl Cancer Res. 2024; 13(7):3798-3813.

PMID: 39145086 PMC: 11319956. DOI: 10.21037/tcr-24-972.

Identification of hub genes and molecular pathways in keratoconus by integrating bioinformatics and literature mining at the RNA level.

Meng F, Ren S Int Ophthalmol. 2024; 44(1):244.

PMID: 38904678 DOI: 10.1007/s10792-024-03071-3.

Systematically Displaying the Pathogenesis of Keratoconus Multi-Level Related Gene Enrichment-Based Review.

Hao X, Gao H, Xu W, Shan C, Liu Y, Zhou Z Front Med (Lausanne). 2022; 8:770138.

PMID: 35141241 PMC: 8818795. DOI: 10.3389/fmed.2021.770138.

Tissue-Derived Biological Particles Restore Cornea Properties in an Enzyme-Mediated Corneal Ectatic Model.

Yin H, Wang X, Majumdar S, Sohn J, Kim B, Stark W Bioengineering (Basel). 2019; 6(4).

PMID: 31569699 PMC: 6956048. DOI: 10.3390/bioengineering6040090.

Transcriptional profiling of corneal stromal cells derived from patients with keratoconus.

Sharif R, Khaled M, McKay T, Liu Y, Karamichos D Sci Rep. 2019; 9(1):12567.

PMID: 31467338 PMC: 6715750. DOI: 10.1038/s41598-019-48983-8.

References

Pares X, Farres J, Kedishvili N, Duester G . Medium- and short-chain dehydrogenase/reductase gene and protein families : Medium-chain and short-chain dehydrogenases/reductases in retinoid metabolism. Cell Mol Life Sci. 2008; 65(24):3936-49. PMC: 2654207. DOI: 10.1007/s00018-008-8591-3. View

Wollensak G, Spoerl E, Seiler T . Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135(5):620-7. DOI: 10.1016/s0002-9394(02)02220-1. View

Sawaguchi S, Twining S, Yue B, Wilson P, Sugar J, Chan S . Alpha-1 proteinase inhibitor levels in keratoconus. Exp Eye Res. 1990; 50(5):549-54. DOI: 10.1016/0014-4835(90)90044-u. View

Duester G . Genetic dissection of retinoid dehydrogenases. Chem Biol Interact. 2001; 130-132(1-3):469-80. DOI: 10.1016/s0009-2797(00)00292-1. View

Hatchell D, Sommer A . Detection of ocular surface abnormalities in experimental vitamin A deficiency. Arch Ophthalmol. 1984; 102(9):1389-93. DOI: 10.1001/archopht.1984.01040031131040. View

Buddi R, Lin B, Atilano S, Zorapapel N, Kenney M, Brown D . Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002; 50(3):341-51. DOI: 10.1177/002215540205000306. View

Kenney M, Chwa M, Atilano S, Tran A, Carballo M, Saghizadeh M . Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci. 2005; 46(3):823-32. DOI: 10.1167/iovs.04-0549. View

Li X, Rabinowitz Y, Tang Y, Picornell Y, Taylor K, Hu M . Two-stage genome-wide linkage scan in keratoconus sib pair families. Invest Ophthalmol Vis Sci. 2006; 47(9):3791-5. DOI: 10.1167/iovs.06-0214. View

Behndig A, Karlsson K, Johansson B, Brannstrom T, Marklund S . Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci. 2001; 42(10):2293-6. View

10.

Gondhowiardjo T, van Haeringen N, Volker-Dieben H, Beekhuis H, Kok J, Van Rij G . Analysis of corneal aldehyde dehydrogenase patterns in pathologic corneas. Cornea. 1993; 12(2):146-54. DOI: 10.1097/00003226-199303000-00010. View

11.

Nielsen K, Heegaard S, Vorum H, Birkenkamp-Demtroder K, Ehlers N, Orntoft T . Altered expression of CLC, DSG3, EMP3, S100A2, and SLPI in corneal epithelium from keratoconus patients. Cornea. 2005; 24(6):661-8. DOI: 10.1097/01.ico.0000153556.59407.69. View

12.

Gondhowiardjo T, van Haeringen N . Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea. 1993; 12(4):310-4. DOI: 10.1097/00003226-199307000-00006. View

13.

Molotkov A, Duester G . Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid. J Biol Chem. 2003; 278(38):36085-90. DOI: 10.1074/jbc.M303709200. View

14.

Smith V, Easty D . Matrix metalloproteinase 2: involvement in keratoconus. Eur J Ophthalmol. 2000; 10(3):215-26. DOI: 10.1177/112067210001000305. View

15.

Smith V, Hoh H, Littleton M, Easty D . Over-expression of a gelatinase A activity in keratoconus. Eye (Lond). 1995; 9 ( Pt 4):429-33. DOI: 10.1038/eye.1995.100. View

16.

Sawaguchi S, Yue B, Sugar J, Gilboy J . Lysosomal enzyme abnormalities in keratoconus. Arch Ophthalmol. 1989; 107(10):1507-10. DOI: 10.1001/archopht.1989.01070020581044. View

17.

Brown D, Chwa M, Opbroek A, Kenney M . Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr Eye Res. 1993; 12(6):571-81. DOI: 10.3109/02713689309001835. View

18.

Karring H, Thogersen I, Klintworth G, Enghild J, Moller-Pedersen T . Proteomic analysis of the soluble fraction from human corneal fibroblasts with reference to ocular transparency. Mol Cell Proteomics. 2004; 3(7):660-74. DOI: 10.1074/mcp.M400016-MCP200. View

19.

Lambiase A, Merlo D, Mollinari C, Bonini P, Rinaldi A, D Amato M . Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3. Proc Natl Acad Sci U S A. 2005; 102(46):16795-800. PMC: 1283852. DOI: 10.1073/pnas.0508516102. View

20.

Zhou L, Sawaguchi S, Twining S, Sugar J, Feder R, Yue B . Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci. 1998; 39(7):1117-24. View